Some price data may be temporarily unavailable.
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
Aerie Pharmaceuticals is a biotechnology company that engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of ophthalmic diseases. The company was founded in 2005 and is headquartered in Bridgewater, New Jersey with research facilities in Research Triangle Park, North Carolina. Aerie Pharmaceuticals, Inc. is a former subsidiary of Duke University Medical Center.
You'd vault skyward, too, if a big-pocketed company were willing to spend a lot of coin on acquiring you.
Wall Street has given the eye-care specialist the cold shoulder in 2020. Is that an opportunity for individual investors?
AERI earnings call for the period ending September 30, 2021.
AERI earnings call for the period ending June 30, 2021.
AERI earnings call for the period ending September 30, 2020.
AERI earnings call for the period ending June 30, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.